Skip to content

6246724f00000763 TSLP mediated signaling pathway Human

Now that I have gathered the necessary information, let me provide a comprehensive review of the GO-CAM model gomodel:6246724f00000763 "TSLP-mediated signaling pathway (Human)".

GO-CAM Model Review: TSLP-mediated signaling pathway (Human)

Model Overview

The model gomodel:6246724f00000763 represents the TSLP-mediated signaling pathway in humans. This pathway begins with TSLP (Thymic Stromal Lymphopoietin) binding to its receptor complex, which consists of IL-7Rα and TSLPR/CRLF2, leading to JAK kinase activation and ultimately STAT5 phosphorylation and nuclear translocation.

Biological Accuracy

The model correctly represents the key steps in TSLP signaling according to current literature:

  1. TSLP as initiator: The model starts with TSLP (UniProtKB:Q969D9) displaying cytokine activity (GO:0005125) in the extracellular space.

  2. Receptor complex: The model shows TSLP signaling through both IL-7Rα (UniProtKB:P16871) and CRLF2/TSLPR (UniProtKB:Q9HC73), which form a heterodimeric receptor complex on the plasma membrane.

  3. JAK-STAT activation: The pathway correctly shows that TSLP signaling activates JAK1 and JAK2 (not JAK3, which would be involved in IL-7 signaling), leading to STAT5A activation and nuclear translocation.

Causal Relationships

The causal relationships in the model follow the expected molecular signaling flow:

  1. TSLP → IL-7R (cytokine receptor activity)
  2. IL-7R → JAK1 and CRLF2 → JAK2 (protein tyrosine kinase activities)
  3. JAK1 and JAK2 → STAT5A (DNA-binding transcription factor activity)

All causal relationships use the RO:0002629 predicate (directly positively regulates), which is appropriate for this signaling pathway.

Areas for Improvement

  1. TSLP receptor complex representation: The model represents the IL-7R and CRLF2 as separate entities with separate causal relationships. According to the "How to annotate complexes in GO-CAM" document, this approach is valid when each subunit has a defined activity. However, since these two proteins form a functional heterodimeric receptor for TSLP, it might be more accurate to explicitly model their coordinated action.

  2. JAK association specificity: While the model correctly shows JAK1 association with IL-7R and JAK2 association with CRLF2, it might be beneficial to add evidence statements to these specific associations since this is a key aspect of TSLP signaling that distinguishes it from IL-7 signaling (which uses JAK1 and JAK3).

  3. STAT5 dimerization: The model currently shows STAT5A activity but doesn't explicitly represent STAT5 dimerization, which is an important step in the signaling process before nuclear translocation.

  4. Part_of biological process annotations: While the model includes several activities that are part_of the "cytokine-mediated signaling pathway" (GO:0019221), this annotation is inconsistently applied across all activities in the model.

Evidence Assessment

The model uses appropriate evidence codes and citations:

  • Most assertions use ECO:0000314 (direct assay evidence) with citation to PMID:20974963, which is a key paper describing TSLP-mediated STAT5 phosphorylation.
  • Cellular locations use ECO:0000305 (curator inference) which is appropriate.
  • The biological process annotations use both direct evidence and biological aspect of ancestor evidence.

Technical Review

  1. All required fields are present: The model includes molecular functions, cellular locations, and appropriate causal relationships.

  2. Nomenclature: All entities use standard nomenclature and proper UniProt accessions.

  3. Automated changes: The model has undergone some automated predicate replacements (RO:0002213 replaced by RO:0002629) and cellular component replacements, which appear to have been done correctly.

Summary and Recommendations

This GO-CAM model accurately represents the TSLP-mediated signaling pathway and is consistent with current literature about this pathway. The key aspects of TSLP signaling, including receptor composition, JAK kinase specificity, and STAT5 activation, are captured correctly.

Recommendations for improvement:

  1. Consider explicitly modeling the IL-7R/CRLF2 heterodimeric complex to better represent their coordinated function in TSLP signaling.

  2. Add more detailed evidence statements for the JAK1/JAK2 associations with specific receptor subunits.

  3. Consider representing STAT5 dimerization as part of the signaling process.

  4. Apply the "part_of cytokine-mediated signaling pathway" annotation consistently to all activities in the pathway.

  5. Consider adding downstream transcriptional targets of STAT5 if they are well-characterized for TSLP signaling.

Overall, this is a high-quality model that accurately represents current knowledge about TSLP signaling through JAK1/JAK2 to STAT5.